[1]刘海英,陈 峰,吴 宁.肝癌TACE术后败血症与骨髓抑制相关性分析 [J].介入放射学杂志,2020,29(10):1033-1035.
 LIU Haiying,CHEN Feng,WU Ning..Analysis of the correlation between septicemia and bone marrow suppression in patients with liver cancer after TACE therapy[J].journal interventional radiology,2020,29(10):1033-1035.
点击复制

肝癌TACE术后败血症与骨髓抑制相关性分析 ()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
29
期数:
2020年10
页码:
1033-1035
栏目:
临床研究
出版日期:
2020-10-25

文章信息/Info

Title:
Analysis of the correlation between septicemia and bone marrow suppression in patients with liver cancer after TACE therapy
作者:
刘海英 陈 峰 吴 宁
Author(s):
LIU Haiying CHEN Feng WU Ning.
Department of Mammary Surgery, Hainan Provincial People’s Hospital, Haikou, Hainan Province 570311, China
关键词:
【关键词】 肝癌 骨髓抑制 化疗 介入治疗 败血症
文献标志码:
A
摘要:
【摘要】 目的 回顾性分析肝癌患者TACE术后2周内出现败血症的好发因素,总结防控对策。方法 收集海南省人民医院2015年1月— 2019年4月接受肝癌介入治疗后经血培养确诊为败血症的11例患者临床资料、实验室检查结果,分析败血症与骨髓抑制的关系。结果 11例患者术后2周内均出现高热(>39.1℃)并伴有白细胞、中性粒细胞、血小板下降等骨髓抑制表现。血培养沙门菌1例,鸟肠球菌1例,铜绿假单胞菌3例,大肠埃希菌4例,肺炎克雷伯菌2例。参考药敏试验,应用抗生素治疗后均好转并出院。结论 TACE术后2周内出现高热并伴有骨髓抑制患者出现败血症的概率明显升高,尽早应用合理抗生素可以有效控制感染。

参考文献/References:

[1] Titano J, Noor A, Kim E. Transarterial chemoembolization and radioembolization across Barcelona clinic liver cancer stages[J]. Semin Intervent Radiol, 2017, 34: 109- 115.
[2] Pinato DJ, Howell J, Ramaswami R, et al. Review article: delivering precision oncology in intermediate- stage liver cancer[J]. Aliment Pharmacol Ther, 2017, 45: 1514- 1523.
[3] Zhu YJ, Zheng B, Wang HY, et al. New knowledge of the mechanisms of sorafenib resistance in liver cancer[J]. Acta Pharmacol Sin, 2017, 38: 614- 622.
[4] 赵传林,于 震,李 伟,等. 原发性肝癌介入化疗患者医院感染的特点与预防研究[J]. 中华医院感染学杂志, 2015, 25:5406- 5408.
[5] Correnti M, Raggi C. Stem- like plasticity and heterogeneity of circulating tumor cells:current status and prospect chanllenges in liver cancer[J]. Oncotarget, 2017, 8: 7094- 7115.
[6] Galperine T, Cazorla C, Blanchard E, et al. Streptococcus canis infections in humans: retrospective study of 54 patients[J]. J Infect, 2007, 55: 23- 26.
[7] Feier D, Lupsorplaton M, StefanescuH, et al. Transientela- stography for the detection of hepatocellular carcinoma in viral C liver cirrhosis.Is there something else than increased liver stiffness?[J]. J Gastrointestin Liver Dis, 2013, 22: 283- 289.
[8] 吴育民,周汝明,梁惠民,等. 肝癌化疗栓塞并发肝脓肿的临床特点及易感因素分析[J]. 中华临床医师杂志(电子版), 2011, 5:343- 346.
[9] 韦小妹,张名林,张 金,等. 肝癌介入化疗患者医院感染的病原菌分布及影响因素分析[J]. 中华医院感染学杂志, 2018, 28:2621- 2624.
[10] 余宏建, 陈俊辉, 陈在中,等. 肝硬化肝癌化疗栓塞后重度骨髓抑制的预防和治疗[J]. 现代医用影像学, 2015, 24:543- 546.
[11] 李同飞,万云云.肿瘤介入化疗对外周血象影响的规律分析[J]. 系统医学, 2017, 2:109- 111.
[12] 罗剑钧,颜志平,王建华,等. 肝动脉化疗栓塞后肝脓肿形成的原因及治疗[J]. 介入放射学杂志, 2001, 10:24- 26.
[13] 尹 君,唐启耀,罗 军. 细菌性肝脓肿的经皮穿刺引流治疗[J]. 介入放射学杂志, 2014, 23:815- 818.
[14] 张和平,王长福,靳海英,等. 恶性肿瘤血管内介入治疗常见不良反应与对策[J]. 实用放射学杂志, 2004, 20:665- 667.
[15] 高 峰,张雪娜,陈茂振,等. 原发性肝癌TACE术后预防性抗生素应用价值研究[J]. 介入放射学杂志, 2013, 22:151- 153.

相似文献/References:

[1]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
 .The volume of Lipiodol used in TACE: its current situation and research progress [J].journal interventional radiology,2012,(10):348.
[2]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
 ,,et al.TACE combined with radiofrequency ablation for massive primary hepatocellular carcinomas: a clinical therapeutic evaluation [J].journal interventional radiology,2012,(10):322.
[3]张   磊,陆骊工,李   勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
 ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(10):968.
[4]敖 劲,张跃伟,徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J].介入放射学杂志,2011,(12):1010.
 AO Jin,ZHANG Yue-wei,XU Ke..Gelatin sponge particle used as an embolic agent in transcatheter arterial chemoembolization treatment for primary hepatocellular carcinoma: its current situation in research[J].journal interventional radiology,2011,(10):1010.
[5]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
 DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(10):75.
[6]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
 ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(10):78.
[7]何海涛,刘 圣,刘建秦,等. 肝癌TACE术并发脑碘油栓塞二例并文献复习[J].介入放射学杂志,2012,(08):682.
 HE Hai- tao,LIU sheng,LIU Jian- qing,et al. Cerebral Lipiodol embolism occurred after transcatheter arterial chemoembolization for hepatocellular carcinoma: report of two cases with literature review[J].journal interventional radiology,2012,(10):682.
[8]罗中华,秦 勉,张学昕,等.原发性肝癌合并下腔静脉及右心房癌栓的动脉内化疗栓塞治疗[J].介入放射学杂志,2012,(12):1035.
 LUO Zhong? hua,QIN Mian,ZHANG Xue? xin,et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma complicated by tumor thrombus in inferior vena cava and right atrium[J].journal interventional radiology,2012,(10):1035.
[9]徐 阳,臧 爽,陈路锋,等.Logistic回归及ROC曲线综合评价血生化指标对肝癌TACE术后发热的预测价值 [J].介入放射学杂志,2013,(06):513.
 XU Yang,ZANG Shuang,CHEN Lu? feng,et al. Combination evaluation of plasma biochemical indexes with Logistic regression and ROC analysis in predicting hyperthermia after transcatheter hepatic arterial chemoembolization for liver cancer[J].journal interventional radiology,2013,(10):513.
[10]彭国文,李晓群. 射频消融及组合方案治疗特殊/高危部位肝癌的中远期疗效[J].介入放射学杂志,2013,(06):525.
 PENG Guo? wen,LI Xiao? qun.. The mid?蛳 to?蛳 long term efficacy of radiofrequency ablation together with combination regimen for the treatment of hepatic carcinomas located at special or high?蛳 risk regions[J].journal interventional radiology,2013,(10):525.

备注/Memo

备注/Memo:
(收稿日期:2019- 08- 07)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2020-10-19